Company Valuation: GKB Ophthalmics Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2020 2021 2022 2023 2024 2025
Market Cap 1 216.7 413.3 463.7 547.2 439.6 304.1
Change - 90.7% 12.2% 17.99% -19.65% -30.82%
Enterprise Value (EV) 1 236.6 363.7 423.1 518.2 382.4 319.7
Change - 53.71% 16.34% 22.46% -26.2% -16.39%
P/E -11.8x -45.5x 36.4x -327x -15.6x -4.32x
PBR 0.37x 0.66x 0.73x 0.87x 0.74x 0.58x
PEG - 0.9x -0x 3x -0x -0x
Capitalization / Revenue 0.37x 0.73x 0.65x 0.72x 0.5x 0.28x
EV / Revenue 0.4x 0.64x 0.6x 0.69x 0.43x 0.29x
EV / EBITDA 10x 15.3x 8.55x 14.1x 66.2x -10.9x
EV / EBIT -18.8x -48.1x 18.5x 60.5x -16.5x -5.3x
EV / FCF -6.6x -38.7x -25.6x -8.45x 15.9x -6.64x
FCF Yield -15.2% -2.58% -3.9% -11.8% 6.28% -15.1%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -3.65 -1.8 2.528 -0.3321 -5.58 -13.98
Distribution rate - - - - - -
Net sales 1 585.3 568.8 709.4 754.7 882.5 1,090
EBITDA 1 23.57 23.83 49.52 36.83 5.779 -29.45
EBIT 1 -12.57 -7.568 22.85 8.561 -23.2 -60.31
Net income 1 -18.4 -9.075 12.74 -1.674 -28.1 -70.45
Net Debt 1 19.86 -49.64 -40.6 -28.99 -57.22 15.59
Reference price 2 43.00 82.00 92.00 108.55 87.22 60.34
Nbr of stocks (in thousands) 5,041 5,041 5,041 5,041 5,041 5,041
Announcement Date 9/4/20 9/3/21 9/7/22 8/22/23 7/25/24 7/24/25
1INR in Million2INR
Estimates

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 3.01M
28.87x2.79x11.78x2.5% 85.56B
31.21x3.22x12.19x0.51% 33.28B
34.52x3.7x11.87x-.--% 13.71B
121.28x8.38x39.71x-.--% 10.04B
18.12x4.41x12.52x1.54% 1.81B
14.77x3.8x8.66x1.81% 1.4B
24.1x4.87x14.95x2.16% 801M
12.94x2.63x6.77x3.12% 787M
18.71x1.27x7.57x1.71% 759M
Average 33.84x 3.90x 14.00x 1.48% 14.81B
Weighted average by Cap. 35.76x 3.38x 13.72x 1.63%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. GKB Stock
  4. Valuation GKB Ophthalmics Limited